The National Medical Products Administration has approved the listing of Olodol clear capsules.

date
16/01/2026
Recently, the National Medical Products Administration approved the listing of the 1st class innovative drug Olologlu net-capsules submitted by Yichang Dongyang Guanglong Pharmaceutical Co., Ltd. This drug is suitable for improving blood sugar control in adult type 2 diabetes patients. The availability of this drug on the market provides patients with a new treatment option.